Under construction – not a live service

Skip to content

Frontlight Research

Trial site

CancerCare Manitoba (Site 0053)

Winnipeg, Manitoba R3E 0V9, CanadaNot linked to an institution yet

1running trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Childhood cancers
Melanoma

Running trials

Active, not recruiting
Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716)
NCT03553836· Phase 3· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – CancerCare Manitoba (Site 0053): trial site – Frontlight Research